RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
ANNALS OF ONCOLOGY
Collezione AO Ordine Mauriziano

Items : 10

The beginning of the COVID-19 era: The perception of oncological patients (pts) in active treatment at the Brindisi and Mauriziano Hospital Oncology Departments in Annals of Oncology

2020
AO Ordine Mauriziano

Loparco D; Di Maio M; Orlando L; Dascanio F; Caliolo C; Ignazzi G; Schiavone P; Lacidogna G; Quaranta A; Marino D; Del Bene G; Vignani F; Fedele P; Sperti E; Caloro M; Terzolo S; D'Amico M; Bellezza A; Comite R; Cinieri S;

CORE-URO-01 study: Comparison of safety and efficacy of pazopanib in first-line metastatic renal cell carcinoma (mRCC) with or without renal failure in Annals of Oncology

2017
AO Ordine Mauriziano
ASL Cuneo 2
AOU San Luigi di Orbassano

Masini C; Vitale MG; Maruzzo M; Procopio G; De Giorgi U; Buti S; Rossetti S; Iacovelli R; Guida A; Atzori F; Mucciarini C; Cosmai L; Vignani F; Prati G; Scagliarini S; Berselli A; Pinto C; Baldari S; Annibale V; Lastoria S; Tucci M; Borsatti E; Monari F; Paganelli G; Verri E; Muto P; Panareo S; Mosca A; Storto G; et alii...

CORE-URO-01 study: Comparison of safety and efficacy of pazopanib in first-line metastatic renal cell carcinoma (mRCC) with or without renal failure in Annals of Oncology

2017
AO Ordine Mauriziano

Masini C; Vitale MG; Maruzzo M; Procopio G; De Giorgi U; Buti S; Rossetti S; Iacovelli R; Guida A; Atzori F; Mucciarini C; Scagliarini S; Vignani F; Prati G; Cosmai L; Berselli A; Pinto C;

Correlation of pd-l1 staining in tumor cells and tumor infiltrate between primary tumors and matched metastasis in advanced colorectal cancer patients in Annals of Oncology

2017
AO Ordine Mauriziano

Tampellini M; Falco E; De Rosa G; Montarolo F; Dacomo R; Baratelli C; Sperti E; Di Maio M; Scagliotti Giorgio V; Volante M;

Nutritional status in elderly cancer patients: Prospective observational study in Annals of Oncology

2017
ASL VCO
AO Ordine Mauriziano

Gagliardi C; Auletta G; Salanitro G; Bolamperti A; Battistella K; Di Vaia M; Rigo C; Suardi B; Renda S; Finale E; Rossin S; Reggiani R; Florio S; Mentone C; Terzolo S;

Germline variants and clinical outcomes of high-risk stage II and stage III colon cancer patients treated with oxaliplatin and fluoropyrimidines adjuvant chemotherapy: A pharmacogenetic ancillary study to TOSCA trial in Annals of Oncology

2017
ASL Biella
AO Ordine Mauriziano

Ruzzo A; Galli F; Rulli E; Lonardi S; Zagonel V; Ronzoni M; Ionta MT; Pella N; Mucciarini C; Labianca R; Veltri E; Sozzi P; Barni S; Nicolini M; Biondi E; Bramati A; Turci D; Buscaglia M; Magnani M; Graziano F; Tampellini M; Falco E; De Rosa G; Montarolo F; Dacomo R; Baratelli C; Sperti E; Di Maio M; Scagliotti GV; et alii...

2017
AO Ordine Mauriziano
AOU Alessandria

Fusco V; Cabras M; Gambino A; Bertetto O; Numico G; De Martino I; Alessio M; Marinella M; Di Maio M; Baratelli C; Bironzo P; Vignani F; Bria E; Sperti E; Marcato M; Roila F;

Systematic review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapy in Annals of Oncology

2016
AO Ordine Mauriziano

Bossi P; Botta L; Bironzo P; Sonetto C; Musettini G; Sbrana A; Di Giannantonio V; Locati L; Di Maio M; Antonuzzo A;

Systematic review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapy in Annals of Oncology

2016
AO Ordine Mauriziano

Bossi P; Botta L; Bironzo P; Sonetto C; Musettini G; Sbrana A; Di Giannantonio V; Locati L; Di Maio M; Antonuzzo A;

Why castration-resistant prostate cancer patients with neuroendocrine differentiation should be addressed to a cisplatin-based regimen in Annals of Oncology

2009
ASL Torino 4
AO Ordine Mauriziano

Vignani F; Russo L; Tucci M; Motta M; Vellani G; Tampellini M; Papotti M; Dogliotti L; Berruti A;